Pantarhei to Bid for Merck & Co., Inc.'s Organon Unit

February 14, 2011 |

1 min read

Reuters) - Dutch bioscience company Pantarhei intends to bid for the bulk of U.S. company Merck's (MRK.N) Netherlands-based bioscience research unit Organan, the Dutch Financieele Dagblad reported on Monday.

Mergers & acquisitions Europe

Merck & Co. Organon

MORE ON THIS TOPIC

Podcast

Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win

April 22, 2026

·

1 min read

·

Heather McKenzie

Thumb up close-up in surgical, medical gloves, gesture, recommendation for a successful operation. Pink background.

Regulatory

Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot

April 22, 2026

·

2 min read

·

Tristan Manalac

Ocean with the wake of the ferry out to Dry Tortugas National Park in Florida Keys

Series A

Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs

April 21, 2026

·

1 min read

·

Gabrielle Masson

Risograph Shopping Cart with geometric shapes. Objects in trendy riso graph print texture style design with geometry elements.

Mergers & acquisitions

Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal

April 20, 2026

·

2 min read

·

Annalee Armstrong